Publicaciones (225) Publicaciones en las que ha participado algún/a investigador/a

2018

  1. Alterations in Gene and Protein Expression of Cannabinoid CB 2 and GPR55 Receptors in the Dorsolateral Prefrontal Cortex of Suicide Victims

    Neurotherapeutics, Vol. 15, Núm. 3, pp. 796-806

  2. Assessment of metabolic patterns and new antitumoral treatment in osteosarcoma xenograft models by [ 18 F]FDG and sodium [ 18 F]fluoride PET

    BMC Cancer, Vol. 18, Núm. 1

  3. A 30-s exposure to ethanol 20% is cytotoxic to human keratinocytes: possible mechanistic link between alcohol-containing mouthwashes and oral cancer

    Clinical Oral Investigations, Vol. 22, Núm. 8, pp. 2943-2946

  4. A lncRNA GUARDINg genome integrity

    Nature Cell Biology, Vol. 20, Núm. 4, pp. 371-372

  5. A new approach to treat joint injuries: Combination of intra-articular and intraosseous injections of platelet rich plasma

    Platelet Rich Plasma in Orthopaedics and Sports Medicine (Springer International Publishing), pp. 145-161

  6. A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients

    Journal of Pathology, Vol. 245, Núm. 4, pp. 421-432

  7. A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis

    Journal for ImmunoTherapy of Cancer, Vol. 6, Núm. 1

  8. A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity

    Nature Communications, Vol. 9, Núm. 1

  9. A “Counter-Enhancer” in Tumor Suppression

    Cell

  10. Absence of MHC-II expression by lymph node stromal cells results in autoimmunity

    Life Science Alliance, Vol. 1, Núm. 6

  11. Adjuvant therapy for colon cancer: Genes, genes. . . And the patient in the center

    Clinical Cancer Research, Vol. 24, Núm. 16, pp. 3787-3789

  12. Allogeneic mesenchymal stem cells and biomaterials: The perfect match for cardiac repair?

    International Journal of Molecular Sciences, Vol. 19, Núm. 10

  13. An Inducible Promoter Responsive to Different Porphyrinogenic Stimuli Improves Gene Therapy Vectors for Acute Intermittent Porphyria

    Human Gene Therapy, Vol. 29, Núm. 4, pp. 480-491

  14. An rna toolbox for cancer immunotherapy

    Nature Reviews Drug Discovery, Vol. 17, Núm. 10, pp. 751-767

  15. Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death

    Neurotherapeutics, Vol. 15, Núm. 4, pp. 1063-1081

  16. Anti-PD1 associated fulminant myocarditis after a single pembrolizumab dose: The role of occult pre-existing autoimmunity

    Haematologica

  17. Antigen phagocytosis by B cells is required for a potent humoral response

    EMBO Reports, Vol. 19, Núm. 9

  18. Are most cancer cases a consequence of an immune deficiency caused by thymic involution?

    Proceedings of the National Academy of Sciences of the United States of America

  19. Autologous bioscaffolds based on different concentrations of platelet rich plasma and synovial fluid as a vehicle for mesenchymal stem cells

    Journal of Biomedical Materials Research - Part A, Vol. 106, Núm. 2, pp. 377-385

  20. Automated database-guided expert-supervised orientation for immunophenotypic diagnosis and classification of acute leukemia

    Leukemia, Vol. 32, Núm. 4, pp. 874-881